REFERENCES
- Hosker HSR, Jones GM, Hawkey P. Management of community acquired lower respiratory tract infection. Br Med J 1994; 308: 701–705.
- Legnani D. Role of oral antibiotics in treatment of community-acquired lower respiratory tract infections. Diagn Microbiol Infect Dis 1997; 27: 41–47.
- Vogel F. A guide to the treatment of lower respiratory tract infections. Drugs 1995; 50: 62–72.
- Felmingham D. Antibiotic resistance. Do we need new therapeutic approaches? Chest 1995; 108 (Suppl 2): 70S-78S.
- Grüneberg RN, Felmingham D and the Alexander Project Group. Results of the Alexander Project: a continuing, multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens. Diagn Microbiol Infect Dis 1996; 25: 169–181.
- Goldstein FW, Garau J. Resistant pneumococci: a renewed threat in respiratory infections. Scand J Infect Dis Suppl 1994; 93: 55–62.
- Liñares, Alonso T, Ayats J, et al. In vitro activity of seven macrolide antibiotics and nine other antimicrobial agents against penicillin-resistant pneumococci. 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, USA 1991: Abstract 191.
- Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 1998; 26: 1–12.
- Gavaldá J, Capdevila JA, Almirante B, Otero J, Ruiz I, Laguarda M, Allende H, Crespo E, Pigrau C, Pahissa A. Treatment of experimental pneumonia due to penicillinresistant Streptococcus pneumoniae in immunocompetent rats. Antimicrob Agents Chemother 1997; 41: 795–801.
- Sanchez C, Armengol R, Lite J, Mir I, Garau J. Penicillin-resistant pneumococci and community-acquired pneumonia. Lancet 1992; 339 (8799): 988.
- Dorca J, Esteban L, Alonso T, Barreito B Verdaguer R, Manresa F. Rapid diagnosis of pneumococcal pneumonia by latex agglutination and CIE in samples obtained by transthoracic needle aspiration. Am Rev Respir Dis 1993; 147: A653.
- American Thoracic Society. Guidelines for the initial management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 1993; 148: 1418–1426.
- Bartlett JG, Breiman RF, Mandell LA, Filet TM. Community-acquired pneumonia in adults: Guidelines for management. Clin Infect Dis 1998; 26: 811–838
- Evans GM, Gainsford WF. Treatment of pneumonia with 2—(p-aminobenzenesulphonamido) pyridine. Lancet 1938; 2: 14–19.
- Guimard J, Correze JR, Choutet P. Les trois references medicales opposables en pathologie infectieuse. La Revue du Praticien 1998; 12: 17–20.
- Garau J. Clinical perspectives of the management of community-acquired pneumonia. Diagn Microbiol Infect Dis 1996; 25: 205–211.
- Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN. A prediction rule to identify low-risk patients with community-acquired pneumonia. NEJM 1997; 336: 243–250.
- Carbon C, Leophonte P. Management of community-acquired pneumonia. J Antimicrob Chemother 1993; 32: 1–3.
- Eron JJ, Burkle W, Cohen MS. Managing pneumonia: defining the role of the new macrolide antibiotics. Hosp Formul 1994 ;29: 136
- Jones RN. Can antimicrobial therapy be sustained? An appraisal of orally administered drugs used for respiratory tract infections. Diagn Microbiol Infect Dis 1997; 27: 21–29.
- PaHares R, Linares J, Vadillo M, Cabellos C, Manresa F, Viladrich PF, Martin R, Gudiol F. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995; 333 (8): 474-480. (Published erratum appears in N Engl J Med 1995; 333 (24): 1655)
- Roson B, Carratala J, Tubau F, Dorca J, Linares J, Manresa F, Gudiol F. Randomized trial of amoxicillin-clavu-lanate vs. ceftriaxone for the treatment of pneumococcal pneumonia in hospitalized patients. 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego CA, USA 1998: Abstract L-107.